alfentanil has been researched along with Cancer of Sigmoid in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
McMunnigall, F; Welsh, J | 1 |
Barritault, L; Chaput, JC; Labaille, T; Limoge, A; Naveau, S | 1 |
2 other study(ies) available for alfentanil and Cancer of Sigmoid
Article | Year |
---|---|
Opioid withdrawal syndrome on switching from hydromorphone to alfentanil.
Topics: Alfentanil; Analgesics, Opioid; Humans; Hydromorphone; Male; Middle Aged; Morphine; Pain, Intractable; Sigmoid Neoplasms; Substance Withdrawal Syndrome; Treatment Outcome | 2008 |
[Electric analgesia and endoscopic laser treatment: morphinans remain indispensable].
Topics: Aged; Aged, 80 and over; Alfentanil; Combined Modality Therapy; Electric Stimulation Therapy; Female; Humans; Intraoperative Care; Laser Therapy; Male; Middle Aged; Morphinans; Pain; Pain Management; Pain, Intractable; Propofol; Rectal Neoplasms; Sigmoid Neoplasms | 1995 |